ClearPoint Neuro, Inc. Common Stock (CLPT)

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ClearPoint Neuro, Inc. Common Stock (CLPT) is listed on Nasdaq, where it has traded since May 18, 2012.

Listed On
Nasdaq
Listed Since
May 18, 2012
Employees
172
Market Cap
$452M

About ClearPoint Neuro, Inc. Common Stock

ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 124 institutions reported holding CLPT, with 13.9 million shares worth $247.6 million in aggregate. The largest reported holder was BlackRock, with 2.4 million shares worth $42.5 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.

InstitutionSharesValueQuarter change
BlackRock2,379,804$42MAdded 14.26%
Mak Capital One2,375,861$42MAdded 24.95%
Vanguard1,650,777$29MReduced 5.36%
State Street816,547$15MAdded 20.11%
Geode Capital Management749,932$13MAdded 6.26%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is CLPT?

ClearPoint Neuro, Inc. Common Stock (CLPT) is listed on Nasdaq, where it has traded since May 18, 2012.

Who are the largest institutional holders of CLPT?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CLPT were BlackRock, Mak Capital One and Vanguard.

How many institutions own CLPT?

124 institutions reported a position in CLPT for the quarter ended June 30, 2026, worth $247.6 million in total.

Did institutions buy or sell CLPT last quarter?

Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for CLPT.

Every reported institutional holder, plus insider and congressional trades in CLPT, on SentiSense.